AstraZeneca has suggested it would have welcomed a bid of £58-a-share after rejecting the offer of £55-a-share by US drug firm Pfizer, ITV News Business Editor Joel Hills reports:
AstraZeneca rebuffs "final" offer of £55/share but seems to suggest that it would have recommended a bid of £58+ to shareholders.
Pfizer has said its bid is "final" and won't go hostile, its only hope now is if AstraZeneca's shareholders rebel against the board.
AstraZeneca's shares closed Friday at £48, before "first contact" were £35. Market opens at 08.00